Jonathan S. Wolin files SEC Form 4 disclosures for Jaguar Health, Inc.. They have made 1 open-market trade across 1 company since 2022, most recently 2025-12-11.
CIK 0001787587
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10 since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JAGX | 11,938 | $42K |
Shares reported on the most recent Form 4, priced at the 2026-01-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAGX | BUY | 2022-12-31 | 2023-01-03 | $0.03 | $10 | +8.1% | -31.4% | -91.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.